Chongqing Lummy Pharmaceutical Total Assets

Latest as of September 2025: CN¥2.76 Billion CNY ≈ $404.21 Million USD

Chongqing Lummy Pharmaceutical total assets. Based on the latest financial reports, Chongqing Lummy Pharmaceutical (300006) holds total assets worth CN¥2.76 Billion CNY (≈ $404.21 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Chongqing Lummy Pharmaceutical market cap and net worth for the company's overall valuation and market capitalisation.

Total Assets of Chongqing Lummy Pharmaceutical (2006–2024)

Total assets of Chongqing Lummy Pharmaceutical from 2006 to 2024. This chart illustrates how Chongqing Lummy Pharmaceutical's total assets have evolved over time, based on quarterly financial data. See current stock price of Chongqing Lummy Pharmaceutical for real-time trading data and today's change.

Chongqing Lummy Pharmaceutical - Asset Composition Analysis

Chongqing Lummy Pharmaceutical Total Assets Breakdown (December 2024)

Chongqing Lummy Pharmaceutical total assets breakdown as of December 2024. Chongqing Lummy Pharmaceutical's total assets of CN¥2.76 Billion consist of 62.0% current assets and 38.0% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	37.5%
Accounts Receivable	CN¥453.42 Million	15.9%
Inventory	CN¥201.70 Million	7.1%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥217.27 Million	7.6%
Goodwill	CN¥44.95 Million	1.6%

Asset Composition Trend (2006–2024)

This chart illustrates how Chongqing Lummy Pharmaceutical's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 300006 current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Chongqing Lummy Pharmaceutical's current assets represent 62.0% of total assets in 2024, a decrease from 64.5% in 2006.
Cash Position: Cash and equivalents constituted 37.5% of total assets in 2024, up from 6.0% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, unchanged from 8.0% in 2006.
Asset Diversification: The largest asset category is accounts receivable at 15.9% of total assets.

Chongqing Lummy Pharmaceutical Competitors by Total Assets

Key competitors of Chongqing Lummy Pharmaceutical based on total assets are shown below.

Company	Country	Total Assets
Merck & Company Inc NYSE:MRK	USA	$129.80 Billion
AstraZeneca PLC NASDAQ:AZN	USA	$114.02 Billion
Pfizer Inc SA:PFIZ34	Brazil	R$201.13 Billion
Novartis AG MX:NVSN	Mexico	MX$118.53 Billion
Pfizer Inc NYSE:PFE	USA	$201.13 Billion
Novo Nordisk A/S CO:NOVO-B	Denmark	Dkr542.90 Billion
Zhejiang Int'L Group Co Ltd SHE:000411	China	CN¥17.31 Billion
SANOFI CONS HEALTHC IND L NSE:SANOFICONR	India	Rs5.47 Billion

Chongqing Lummy Pharmaceutical - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.04	2.35	1.00
Quick Ratio	1.83	2.11	0.82
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥852.78 Million	CN¥1.06 Billion	CN¥-4.58 Million

Chongqing Lummy Pharmaceutical - Advanced Valuation Insights

This section examines the relationship between Chongqing Lummy Pharmaceutical's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.93
Latest Market Cap to Assets Ratio	0.52
Asset Growth Rate (YoY)	-1.2%
Total Assets	CN¥2.86 Billion
Market Capitalization	$1.47 Billion USD

Valuation Analysis

Below Book Valuation: The market values Chongqing Lummy Pharmaceutical's assets below their book value (0.52x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Chongqing Lummy Pharmaceutical's assets decreased by 1.2% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Chongqing Lummy Pharmaceutical (2006–2024)

The table below shows the annual total assets of Chongqing Lummy Pharmaceutical from 2006 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥2.86 Billion ≈ $417.89 Million	-1.21%
2023-12-31	CN¥2.89 Billion ≈ $423.03 Million	-5.37%
2022-12-31	CN¥3.05 Billion ≈ $447.04 Million	+4.38%
2021-12-31	CN¥2.93 Billion ≈ $428.28 Million	-7.02%
2020-12-31	CN¥3.15 Billion ≈ $460.62 Million	-10.10%
2019-12-31	CN¥3.50 Billion ≈ $512.37 Million	+11.48%
2018-12-31	CN¥3.14 Billion ≈ $459.59 Million	+14.61%
2017-12-31	CN¥2.74 Billion ≈ $401.00 Million	+10.32%
2016-12-31	CN¥2.48 Billion ≈ $363.50 Million	-19.94%
2015-12-31	CN¥3.10 Billion ≈ $454.03 Million	+38.28%
2014-12-31	CN¥2.24 Billion ≈ $328.35 Million	+2.83%
2013-12-31	CN¥2.18 Billion ≈ $319.31 Million	+53.27%
2012-12-31	CN¥1.42 Billion ≈ $208.34 Million	+31.71%
2011-12-31	CN¥1.08 Billion ≈ $158.18 Million	+22.28%
2010-12-31	CN¥884.01 Million ≈ $129.36 Million	+35.25%
2009-12-31	CN¥653.63 Million ≈ $95.65 Million	+143.38%
2008-12-31	CN¥268.56 Million ≈ $39.30 Million	+25.09%
2007-12-31	CN¥214.69 Million ≈ $31.42 Million	+71.61%
2006-12-31	CN¥125.10 Million ≈ $18.31 Million	--

About Chongqing Lummy Pharmaceutical

SHE:300006 China Drug Manufacturers - General

Market Cap

$1.47 Billion

CN¥10.06 Billion CNY

Market Cap Rank

#7078 Global

#1450 in China

Share Price

CN¥9.53

Change (1 day)

+4.38%

52-Week Range

CN¥4.43 - CN¥10.48

All Time High

CN¥11.34